Dr. Lukas J. Farbiak is a biomedical engineering innovator and academic leader whose work in genetic medicine is transforming how diseases are treated at the molecular level. As an Assistant Professor at UT Southwestern and Co-Founder of Signify Bio, Inc., he merges deep scientific expertise with translational impact—developing advanced lipid nanoparticle platforms and signal peptide technologies that enable precise, tissue-specific delivery of therapeutic nucleic acids. With over 15 peer-reviewed publications and 20+ patent filings, Dr. Farbiak stands at the cutting edge of non-viral drug delivery and personalized therapeutics, bringing a rare blend of academic rigor, entrepreneurial vision, and collaborative leadership to every endeavor.

Excited to share my executive biography, highlighting my journey in digital transformation, AI, and manufacturing innovation. With over 23 years of experience, I am passionate about leveraging technology to drive business success and mentoring teams to achieve excellence.